Bio Protech

XKON-199290
Korea New Exchange
Surgical and Medical Instruments and Apparatus
Global Rank
#43981
Country Rank
#2657
Market Cap
5.19 M
Price
0.338
Change (%)
4.67%
Volume
2

Bio Protech's latest marketcap:

5.19 M

As of 08/15/2025, Bio Protech's market capitalization has reached $5.19 M. According to our data, Bio Protech is the 43981th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 5.19 M
Revenue (ttm) 0
Net Income (ttm) 0
Shares Out 14.47 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 08/15/2025

Bio Protech's yearly market capitalization.

Bio Protech has seen its market value drop from ₩8.9 B to ₩7.2 B since 2017, representing a total decrease of 19.07% and an annual compound decline rate (CAGR) of 2.74%.
Date Market Cap(₩) Market Cap(USD) Change (%) Global Rank
08/15/2025 ₩7.2 B $5.19 M -17% 43981
12/27/2024 ₩8.68 B $5.82 M -34.07% 40349
12/28/2023 ₩13.16 B $10.14 M -15.35% 37047
12/28/2022 ₩15.55 B $12.28 M 315.38% 35068
12/30/2021 ₩3.74 B $3.14 M -60.75% 38177
03/19/2020 ₩9.54 B $8.78 M 17.2% 32512
12/30/2019 ₩8.14 B $7 M -23.56% 29903
12/28/2018 ₩10.65 B $9.48 M 19.61% 28013
12/28/2017 ₩8.9 B $8.28 M 28094

Company Profile

About Bio Protech Inc.

Bio Protech Inc. is a global manufacturer and supplier of medical supplies, founded in 2000 and headquartered in Wonju, South Korea. The company specializes in a diverse range of medical products designed for various healthcare applications.

Product Offerings

  • Electrosurgical Products: Smoke evacuators, telescopic smoke pencils, economy smoke pencils, dual extension smoke pencils, surgical pencils, surgical smoke adapters, laparoscopic products, and ESU plates.
  • Cardiology Products: ECG electrodes, TAB electrodes, neonatal electrodes, and SpO2 sensors.
  • Neurology Products: EMG needles and electrodes, EEG cups electrodes, surface electrodes, IOM needles, and neurology cables.
  • Pain Management Solutions:
    • PROTENS: Conductive interface for transcutaneous electrical nerve stimulators (TENS).
    • MAXTENS 1000/2000: Advanced pain relief devices.
    • MAXEMS 1000/2000: Battery-operated pulse generators for muscle stimulation.
    • MAX-IF 1000: Electrical impulse device for pain signal interruption.

With a commitment to innovation and quality, Bio Protech Inc. continues to serve the medical industry with reliable and effective healthcare solutions.

Frequently Asked Questions

  • What is Bio Protech's (XKON-199290) current market cap?
    As of 08/15/2025, Bio Protech (including the parent company, if applicable) has an estimated market capitalization of $5.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Bio Protech global market capitalization ranking is approximately 43981 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.